Enveric Biosciences ENVB
NASDAQ ENVB
$1.38 -0.01 (-0.72%)
As of: Aug 21, 2026 · 12:44 PM EDT

Enveric Biosciences (ENVB) EBT Margin (QoQ) (2015 - 2020)

Enveric Biosciences (ENVB) EBT Margin (QoQ) (2015 - 2020) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.57 Bn 131.72 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.71 Bn 78.72 Bn 3.93 Bn
3 Argenx Se 65.44 Bn 60.25 Bn 1.37 Bn
4 Moderna 60.06 Bn 54.93 Bn 52.00 Mn
5 BeOne Medicines 42.16 Bn 37.06 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.89 Bn 28.58 Bn 992.69 Mn
7 BioNTech SE 28.11 Bn 9.72 Bn 668.28 Mn
8 Insmed 27.59 Bn 26.43 Bn 358.27 Mn
9 Royalty Pharma 27.33 Bn 26.49 Bn -
10 Enveric Biosciences 5.50 Mn -2.79 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2020 719.00
Jun 30, 2020 -49.00
Mar 31, 2020 512.00
Dec 31, 2019 -2,392.00
Sep 30, 2019 1,170.00
Jun 30, 2019 644.00
Mar 31, 2019 11,302.00
Dec 31, 2018 -18,484.00
Sep 30, 2018 6,550.00
Jun 30, 2018 283.00
Mar 31, 2018 1,562.00
Dec 31, 2017 259.00
Sep 30, 2017 -580.00
Jun 30, 2017 -2,073.00
Mar 31, 2017 1,384.00
Dec 31, 2016 -205.00
Sep 30, 2016 41.00
Jun 30, 2016 -246.00
Mar 31, 2016 807.00
Dec 31, 2015 -1,522.00